Form 4: Medpace Holdings Director Acquires Stock Options

Robert O. Kraft, a director of Medpace Holdings, Inc., acquired 1,224 stock options at a price of $305.66 on May 16, 2025, according to a Form 4 filing.

Summary

• Robert O. Kraft, a director at Medpace Holdings, Inc. (MEDP), filed a Form 4 indicating a change in beneficial ownership.
• The transaction occurred on May 16, 2025.
• Kraft acquired 1,224 stock options with an exercise price of $305.66.
• These options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
• Following the transaction, Kraft directly owns 1,224 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing (Form 4) detailing a director's acquisition of stock options. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation in the pharmaceutical and healthcare industries.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in publicly traded companies, particularly in the healthcare and pharmaceutical sectors.
• Companies like ICON plc and IQVIA Holdings also utilize stock options as part of their compensation strategy to align executive interests with shareholder value.
• The vesting schedule described is fairly standard, often tied to continued service and/or company performance metrics.

Key Dates

Keywords

Form 4, Medpace Holdings, Stock Options, Robert O. Kraft, Director, Beneficial Ownership, MEDP